Regencell Bioscience Holdings (Regencell Bioscience Holdings) ROE % Adjusted to Book Value : -1.59% (As of Jun. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Regencell Bioscience Holdings ROE % Adjusted to Book Value?

Regencell Bioscience Holdings's ROE % for the quarter that ended in Jun. 2023 was -39.63%. Regencell Bioscience Holdings's PB Ratio for the quarter that ended in Jun. 2023 was 24.94. Regencell Bioscience Holdings's ROE % Adjusted to Book Value for the quarter that ended in Jun. 2023 was -1.59%.

Regencell Bioscience Holdings ROE % Adjusted to Book Value Historical Data

The historical data trend for Regencell Bioscience Holdings's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Regencell Bioscience Holdings ROE % Adjusted to Book Value Chart

Regencell Bioscience Holdings Annual Data

Trend

Jun19

Jun20

Jun21

Jun22

Jun23

ROE % Adjusted to Book Value

-4.32

-1.62

Regencell Bioscience Holdings Semi-Annual Data
	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
ROE % Adjusted to Book Value	Get a 7-Day Free Trial				-	-4.36	-1.59	-1.64	-1.59

Competitive Comparison of Regencell Bioscience Holdings's ROE % Adjusted to Book Value

For the Drug Manufacturers - Specialty & Generic subindustry, Regencell Bioscience Holdings's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Regencell Bioscience Holdings's ROE % Adjusted to Book Value Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Regencell Bioscience Holdings's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Regencell Bioscience Holdings's ROE % Adjusted to Book Value falls into.

Regencell Bioscience Holdings ROE % Adjusted to Book Value Calculation

Regencell Bioscience Holdings's ROE % Adjusted to Book Value for the fiscal year that ended in Jun. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-40.36%	/	24.94
	=	-1.62%

Regencell Bioscience Holdings's ROE % Adjusted to Book Value for the quarter that ended in Jun. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-39.63%	/	24.94
	=	-1.59%

Regencell Bioscience Holdings ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Regencell Bioscience Holdings's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Regencell Bioscience Holdings (Regencell Bioscience Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Regencell Bioscience Holdings Ltd (NAS:RGC) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

N/A

Address

29 Leighton Road, 9/F Chinachem Leighton Plaza, Causeway Bay, Hong Kong, HKG

Website

https://www.regencellbioscience.com

Regencell Bioscience Holdings Ltd is engaged in the research, development and commercialization of traditional Chinese medicine. The medicines are used for the treatment of neurocognitive disorders and degeneration.